The recommendation follows review and analysis of clinical trials for the  monoclonal antibodies mAb114 (known as Ansuvimab or Ebanga) and REGN-EB3 (Inmazeb), which have demonstrated clear benefits for people who have tested positive for Ebola, which is often fatal.  This includes older persons, pregnant and breastfeeding women, children, and newborns whose mothers were confirmed to have Ebola within the first… Read More

The recommendation comes in a statement issued by the Strategic Advisory Group of Experts (SAGE) on Immunization, following a meeting held last week.   Most COVID-19 vaccines consist of a primary series of two doses, with a first booster administered some four to six months after completion to improve immune response.  “There is increasing evidence on the benefits of a… Read More

“Almost 7,500 cases were reported last week, a 20 per cent increase over the previous week, which was also 20 per cent more than the week before,” said WHO Director General Tedros Adhanom Ghebreyesus, speaking during his regular press briefing from Geneva.  “The primary focus for all countries must be to ensure they are ready for #monkeypox & stop transmission… Read More

In addition to health and laboratory supplies, it has supported specialized trauma teams and joined field missions along with national health authorities and other humanitarian partners. “The risk of water- and vector-borne diseases, including malaria, cholera and other communicable diseases is unfolding,” warned Adham Rashad, WHO Representative to Yemen. Evolving trauma Triggered by the heavy seasonal rains, extensive floods have ravaged… Read More

The landmark award, valued at up to $170 million, will lead to 18 million doses of the RTS,S vaccine being available over the next three years, potentially saving thousands of young lives annually.   The delivery of this malaria vaccine will bring hope to so many families. In 2020, nearly half a million children died from malaria in Africa alone, a… Read More